Team:PKU Beijing/Project/Output
From 2009.igem.org
(→Testing) |
(→Testing) |
||
(2 intermediate revisions not shown) | |||
Line 11: | Line 11: | ||
[[Image:PKU_OR_OUTPUT.png|600px|thumb|center|fig1. OR Gate and Output]] | [[Image:PKU_OR_OUTPUT.png|600px|thumb|center|fig1. OR Gate and Output]] | ||
- | In [ | + | In [https://2007.igem.org/Cambridge/Amplifier_project Cambridge 2007 Amplifier project], the PhiR73 activator and the PO promoter is used to amplify signal from an inducible promoter. |
- | [[Image:PKU_Cambridge_AgrAmp.png|600px|thumb|center|fig2. Cambridge 2007 amplifier project <br>''picture from [ | + | [[Image:PKU_Cambridge_AgrAmp.png|600px|thumb|center|fig2. Cambridge 2007 amplifier project <br>''picture from [https://2007.igem.org/Cambridge/Amplifier_project Cambridge 2007 page'']]] |
In order to make the transcription level from PO promoter similar to that of the sal promoter, the activator is designed to be on a lower copy plasmid than the reporter. This is also discussed in the second stage assembly section. | In order to make the transcription level from PO promoter similar to that of the sal promoter, the activator is designed to be on a lower copy plasmid than the reporter. This is also discussed in the second stage assembly section. | ||
Line 25: | Line 25: | ||
The first strain is to test the PO promoter, which consists of an PhiR73 activator that can be induced by salicylate. | The first strain is to test the PO promoter, which consists of an PhiR73 activator that can be induced by salicylate. | ||
The Second strain is to test the Salicylate promoter(after PO promoter is inserted in between the pSal and the Transcriptional Unit). | The Second strain is to test the Salicylate promoter(after PO promoter is inserted in between the pSal and the Transcriptional Unit). | ||
- | |||
- | |||
The result of the induction is shown right: | The result of the induction is shown right: | ||
Fig3 shows the result of the first strain induced by salicylate. Fig4 shows that of second strain, induced by salicylate. | Fig3 shows the result of the first strain induced by salicylate. Fig4 shows that of second strain, induced by salicylate. | ||
+ | |||
+ | {|cellpadding=5 | ||
+ | |[[Image:OR_Gate_Sal.JPG|150px|right|thumb]]|||Fig4. OR Gate activated by Salicylate. In order to see whether the inserted PO has blocked the function of the salicylate inducible promoter, we use salicylate to induce the strain. Fluorescence is observed, which demonstrates that salicylate promoter works in the OR Gate. | ||
+ | |} | ||
+ | {|cellpadding=5 | ||
+ | |[[Image:PKU_OR_PO.JPG|150px|right|thumb]]|||Fig3. PO-GFP Gate activated by PhiR73 delta. We believe that if PO-GFP can be activated, there is no problem that it can be still activated when pSal is placed upstream of it. | ||
+ | |} | ||
{{PKU_Beijing/Foot}} | {{PKU_Beijing/Foot}} |
Latest revision as of 15:57, 21 October 2009
|
|||||||||||||
|
|||||||||||||